Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

4.2 Abstract in Atti di convegno: [188] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 188
Titolo Data di pubblicazione Autore(i) File
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 1-gen-2003 Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G
Targeted therapy for ovarian cancer 1-gen-2004 Legge, F; Ferrandina, G; Scambia, G
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 1-gen-2007 Fagotti, A; Ferrandina, G; Paris, I; Mari, A; Legge, F; Fanfani, F; Facchini, G; Scambia, G
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 1-gen-2009 Restaino, G; Missere, M; Maselli, G; Mattioni, O; Calandriella, L; Carone, V; Legge, F; Ferandina, G; Sallustio, G
Endometriosis and Cancer 1-gen-2009 Legge, F; Paglia, A; D’Asta, M; Carone, V; Scambia, G; Ferrandina, G
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 1-gen-2006 Ferrandina, G; Ludovisi, M; D’Agostino, G; Naldini, A; Lorusso, D; Testa, Ac; Legge, F; Salutari, V; Scambia, G
Gene therapy in gyncological cancer 1-gen-2001 Scambia, G; Ferrandina, G; Legge, F; Fagotti, A; Fanfani, F; Mancuso, S
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 1-gen-2003 Ferrandina, G; Salutari, V; Legge, F; Ranelletti, Fo; Distefano, Mg; Gessi, M; Zannoni, Gf; Martinelli, E; Gallotta, V; Scambia, G
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 1-gen-2005 Legge, F; Ranelletti, Fo; Zannoni, Gf; Martinelli, E; Gessi, M; Salutari, V; Gallotta, V; Lorusso, D; Scambia, G; Ferrandina, G
New drugs in ovarian cancer 1-gen-2005 Legge, F; Ferrandina, G; Salutari, V; Scambia, G
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 1-gen-2003 Ferrandina, G; Ranelletti, Fo; Legge, F; Lauriola, L; Salutari, V; Gessi, M; Testa, Ac; Werner, U; Navarra, P; Tringali, G; Battaglia, A; Pozzo, C; Scambia, G
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? 1-gen-2012 Legge, F; Petrillo, M; Pedone, L; Lucidi, A; Malaggese, M; Iannone, V; Borriello, M; Carone, V; Scambia, G; Ferrandina, G
Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome 1-gen-2012 Iannone, V; Paglia, A; Martinelli, E; Fuoco, G; Legge, F; Borriello, M; Pedone, L; Zannoni, Gf; Carone, V; Ferrandina, G
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 1-gen-2012 Macchia, G; Morganti, Ag; Deodato, F; Cilla, S; Corrado, G; Legge, F; Malaggese, M; Massacesi, M; Scambia, G; Ferrandina, G
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 1-gen-2000 Scambia, G; Fagotti, A; Legge, F; Ferrandina, G; Fanfani, F; Mancuso, S
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 1-gen-2008 Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Ruggieri, V; Cocciolo, A; Travaglini, C; Piscopo, A; Ferrandina, G; Scambia, G; Valentini, V; Cellini, N
Il carcinoma ovarico familiare 1-gen-2000 Greggi, S; Legge, F; Laurelli, G; Paparatti, M
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 1-gen-2010 Pignata, S; Scambia, G; Savarese, A; Sorio, R; Breda, E; Legge, F; Gebbia, V; Musso, P; Gallo, C; Perrone, F on behalf of MITO group
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 1-gen-2008 Ferrandina, G; Lorusso, D; Ludovisi, M; Pignata, S; Sorio, R; Mangili, G; Breda, E; Legge, F; Pisconti, S; Scambia, G
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 1-gen-2008 Macchia, G; Morganti, Ag; Legge, F; Deodato, F; Digesù, C; Ferro, M; Caravatta, L; Tambaro, R; Ferrandina, G; Sallustio, G; Smaniotto, D; Scambia, G; Valentini, V; Cellini, N
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 188
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 4 Contributo in Atti di Convegno ...188
Autore
  • SIMONETTI, VALENTINA55
  • LEGGE, FRANCESCO36
  • D'ADAMO, MARIA CRISTINA 31
  • FRATANTONIO, DEBORAH 22
  • BUSSOLI, CANDIDA8
  • EPICOCO, NICOLA6
  • RUBINO, MICHELE5
  • VITOLLA, FILIPPO5
  • AMORUSO, PAOLA4
  • FAZIO, LEONARDO4
Data di pubblicazione
  • 2020 - 202331
  • 2010 - 201993
  • 2000 - 200948
  • 1992 - 199916
Editore
  • Elsevier2
  • Edizioni MAF Servizi1
  • OXFORD UNIV PRESS1
  • Rogiosi Editore1
  • Società Italiana di Farmacologia1
Rivista
  • ACTA PHYSIOLOGICA7
  • BIOPHYSICAL JOURNAL7
  • JOURNAL OF CLINICAL ONCOLOGY5
  • THROMBOSIS RESEARCH5
  • THROMBOSIS AND HAEMOSTASIS4
  • INTERNATIONAL JOURNAL OF GYNECOLO...3
  • SCHIZOPHRENIA BULLETIN3
  • CANCER RESEARCH2
  • FIBRINOLYSIS2
  • PHARMACOLOGICAL RESEARCH2
Keyword
  • N.A2
  • n.a2
  • public health2
  • anthocyanins1
  • biobanking1
  • cardiovascular risk1
  • childhood obesity1
  • economic evaluation1
  • epidemiology1
  • epigenetics1
Lingua
  • eng88
  • ita10
Accesso al fulltext
  • no fulltext188